Brighthouse Financial heads into its August 7 earnings release with short sellers firmly positioned and options traders adding a modest layer of caution — yet the borrow market itself raises no alarm.
Short interest is the central tension here. At 9.3% of the free float, it represents a genuinely elevated short position — one that has held remarkably steady for weeks, drifting only fractionally lower over the past month. The bears have not retreated. Borrowing costs remain negligible at 0.39%, and borrow availability is exceptionally loose at over 1,400% — meaning there is roughly 14 shares available for every one currently borrowed. That combination tells a specific story: short sellers are comfortable holding their positions without any squeeze pressure, and new shorts face no friction in entering. On the price side, the stock has slipped 3.4% over the past month to $61.86, with no meaningful recovery ahead of the print.
Options positioning has edged more defensive than usual into the event. The put/call ratio rose to 0.70, running roughly 1.4 standard deviations above its 20-day average of 0.65. That is not an extreme reading — the 52-week high is 1.65 — but the directional move is notable. Over the past month, the ratio has climbed steadily from near its annual low, suggesting that hedging demand has picked up alongside the stock's drift lower. It reinforces the cautious tilt rather than signalling outright bearish conviction.
The analyst community is broadly sidelined on BHF, with a consensus hold and a mean price target around $65 implying modest upside from current levels. The most recent activity worth noting came from Keefe, Bruyette & Woods, which reinstated coverage in late March at Market Perform with a $67 target — effectively a neutral read. Barclays downgraded the stock to Equal-Weight in January. The ORTEX short score, running near 58 on a scale where higher means more bearish pressure, has been essentially flat for two weeks, suggesting the positioning story has stabilised rather than escalated. On valuation, the stock trades at just 3.1x trailing earnings and 0.6x book — metrics that reflect the market's persistent scepticism about reserve adequacy and spread income sustainability at a life insurer highly sensitive to rate movements. A year-on-year forward EPS increase ranking in the 90th percentile of the universe points to meaningful expected earnings growth, yet the EPS surprise factor ranks near the bottom — a combination that sets a tricky expectations bar.
Past earnings prints have not been kind to the bulls. Each of the four most recent results events produced a negative one-day reaction, ranging from a mild -0.4% to a sharper -3.2%. The five-day follow-through has also leaned negative, most notably after the February 2026 result, which produced a -6.3% five-day move. Tomorrow's print is therefore less a question of whether BHF can grow earnings, and more a test of whether management can credibly address reserve and capital concerns that have kept the Street neutral and kept nearly a tenth of the float borrowed against the stock.
See the live data behind this article on ORTEX.
Open BHF on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
